Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

06 Nov, EOD - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, EOD - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5922.02 (2.32)

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 532321 | NSE Symbol : ZYDUSLIFE | ISIN : INE010B01027 | Industry : Pharmaceuticals |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Sale of Products	10,317.60	8,421.20	7,590.00	7,436.70	5,967.70
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	501.10	310.40	246.90	343.30	379.70
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Other Income	1,084.80	548.40	178.70	89.30	849.40
Total Revenue	11,903.50	9,280.00	8,015.60	7,869.30	7,196.80
Changes in Inventories	-131.70	105.10	-46.90	-148.30	15.50
Cost of Material Consumed	3,001.40	2,703.50	2,629.00	2,346.40	1,838.30
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	283.20	362.70	288.10	153.30	97.90
Employee Benefits	1,507.50	1,321.90	1,204.90	1,147.30	1,077.40
Total Other Expenses	2,099.60	1,784.00	1,843.70	1,972.60	1,895.20
Manufacturing / Operating Expenses	645.40	611.10	626.30	556.60	535.70
Administrative and Selling Expenses	1,016.00	1,039.80	958.40	1,009.10	925.30
Other Expenses	438.20	133.10	259.00	406.90	434.20
Finance Costs	390.70	278.20	134.90	70.90	233.90
Depreciation and Amortization	504.40	488.60	478.70	451.10	428.90
Total Expenses	7,655.10	7,044.00	6,532.40	5,993.30	5,587.10
Profit Before Exceptional Items and Tax	4,248.40	2,236.00	1,483.20	1,876.00	1,609.70
Exceptional Items Before Tax	-8.60	-203.80	-319.30	-187.50	-52.00
Profit Before Extraordinary Items and Tax	4,239.80	2,032.20	1,163.90	1,688.50	1,557.70
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	4,239.80	2,032.20	1,163.90	1,688.50	1,557.70
Taxation	798.30	503.00	306.00	212.30	204.10
Current Tax	934.30	464.10	260.20	303.20	164.60
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-136.00	41.20	45.80	-91.00	40.00
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	-2.30	0.00	0.10	-0.50
Profit After Tax	3,441.50	1,529.20	857.90	1,476.20	1,353.60
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	59.30
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	68.20
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	-8.90
Profit Attributable to Shareholders	3,441.50	1,529.20	857.90	1,476.20	1,412.90
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	3,441.50	1,529.20	857.90	1,476.20	1,412.90
Earning Per Share - Basic	34.01	15.06	8.38	14.42	13.80
Earning Per Share - Diluted	34.01	15.06	8.38	14.42	13.80

LOGIN HERE

LOGIN HERE

Zydus Lifesciences Ltd

Profit and Loss